JP2024507732A5 - - Google Patents

Info

Publication number
JP2024507732A5
JP2024507732A5 JP2023547629A JP2023547629A JP2024507732A5 JP 2024507732 A5 JP2024507732 A5 JP 2024507732A5 JP 2023547629 A JP2023547629 A JP 2023547629A JP 2023547629 A JP2023547629 A JP 2023547629A JP 2024507732 A5 JP2024507732 A5 JP 2024507732A5
Authority
JP
Japan
Prior art keywords
anerovirus
aav
nucleic acid
therapeutic
exogenous
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2023547629A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024507732A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/015499 external-priority patent/WO2022170195A1/en
Publication of JP2024507732A publication Critical patent/JP2024507732A/ja
Publication of JP2024507732A5 publication Critical patent/JP2024507732A5/ja
Withdrawn legal-status Critical Current

Links

JP2023547629A 2021-02-08 2022-02-07 ハイッブリッドaav-アネロベクター Withdrawn JP2024507732A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163147102P 2021-02-08 2021-02-08
US63/147,102 2021-02-08
PCT/US2022/015499 WO2022170195A1 (en) 2021-02-08 2022-02-07 Hybrid aav-anellovectors

Publications (2)

Publication Number Publication Date
JP2024507732A JP2024507732A (ja) 2024-02-21
JP2024507732A5 true JP2024507732A5 (https=) 2025-02-17

Family

ID=82742534

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023547629A Withdrawn JP2024507732A (ja) 2021-02-08 2022-02-07 ハイッブリッドaav-アネロベクター

Country Status (9)

Country Link
US (1) US20240123083A1 (https=)
EP (1) EP4288115A4 (https=)
JP (1) JP2024507732A (https=)
KR (1) KR20230146560A (https=)
CN (1) CN117279669A (https=)
AU (1) AU2022216311A1 (https=)
CA (1) CA3210500A1 (https=)
IL (1) IL304741A (https=)
WO (1) WO2022170195A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN119320802A (zh) * 2023-07-17 2025-01-17 苏州吉恒基因科技有限公司 单链单极DNA重组腺相关病毒的cis包装元件、spAAV载体和应用
WO2025160409A1 (en) 2024-01-26 2025-07-31 Flagship Pioneering Innovations V, Inc. Viral vectors for modulating vegf function

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL271275B1 (en) * 2017-06-13 2026-04-01 Flagship Pioneering Innovations V Inc Preparations containing croons and their uses
CN111989396A (zh) * 2017-11-30 2020-11-24 宾夕法尼亚州大学信托人 用于iiib型粘多糖贮积病的基因疗法
AU2019396520A1 (en) * 2018-12-12 2021-05-27 Flagship Pioneering Innovations V, Inc. Anellosomes for delivering secreted therapeutic modalities
KR20230036109A (ko) * 2020-06-12 2023-03-14 플래그쉽 파이어니어링 이노베이션스 브이, 인크. 바큘로바이러스 발현 시스템

Similar Documents

Publication Publication Date Title
KR100525687B1 (ko) 재조합체 센다이바이러스
JP7069426B2 (ja) ユートロフィン遺伝子を標的とした筋ジストロフィーの治療方法
JP6322605B2 (ja) 組換えaavベクターの高力価ヘルパーなし調製物を生成するための方法
JP2021515548A5 (https=)
JP2022091989A5 (https=)
EP3003391B1 (en) Adeno-associated virus variants and methods of use thereof
JP2022530544A5 (https=)
JP2022530633A5 (https=)
JP2022530656A5 (https=)
JP4472182B2 (ja) 放出された組換えaavベクターの高力価のヘルパーを含まない調製物を生成するための方法
WO2022187548A1 (en) Controlled expression of viral proteins
CN110950934B (zh) 一种腺相关病毒衣壳蛋白、载体及其构建方法与应用
US20250223592A1 (en) Compositions and methods for circular rna affinity purification
JP2024507732A5 (https=)
JP2023550581A5 (https=)
CN118480098B (zh) 腺相关病毒突变体及其应用
WO2008124015A1 (en) Methods for purifying adeno-associated virus virions
CN112680443A (zh) 一种启动子pCalm1及其应用
CN104497118B (zh) 一种昆虫蛋白Hig及其编码基因和应用
CN116284262B (zh) 高效感染ht-22细胞的腺相关病毒突变体
CN116102665B (zh) 一种特异性感染l6细胞的腺相关病毒突变体
CN115991743B (zh) 一种高效感染ht-22细胞的腺相关病毒突变体
CN118853669A (zh) 一种增强肌肉特异性基因表达的增强子及其用途
TW202528335A (zh) 衣殼多肽及其使用方法(一)
WO2025231397A1 (en) Modified hek cell lines for improved aav production